Is This The Time To Buy Pharma and Biotech Stocks?

Certainly there’s been lots of press about their P/E ratios being historically low especially at some of the blue chips like Pfizer. There are good reasons like limited pipelines and generic competition. And, generally, my opinion is that if everyone’s talking about it then you’ve missed your window.

That being said, I found this chart very interesting. It came out from Citigroup months ago, but if I interpret it right than it shows a typical uptick in those stocks in the upcoming months. [Note: This should not serve as investment advice but simply presentation of data. Any investments should be made based on your own research and the advice of your advisors.]

If it’s hard to read, the title says “S&P 500 Pharma & Biotech: Average Relative Performance & Frequency of Relative Gains, By Month, Since 1989”. So, in September, these stocks have gained an average of 1.59% with a frequency of 65%.


No comments yet... Be the first to leave a reply!

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: